LT
ABBV icon

Legacy Trust’s AbbVie ABBV Stock Holding History

Legacy Trust’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.44M Buy
8,263
+402
+5% +$103K 0.41% 60
2026
Q2 		$1.98M Sell
7,861
-316
-4% -$68K 0.35% 62
2026
Q1 		$1.78M Buy
8,177
+814
+11% +$181K 0.34% 60
2025
Q4 		$1.68M Buy
7,363
+321
+5% +$73.1K 0.31% 62
2025
Q3 		$1.63M Buy
7,042
+4,583
+186% +$933K 0.32% 63
2025
Q2 		$456K Sell
2,459
-52
-2% -$9.7K 0.11% 107
2025
Q1 		$526K Sell
2,511
-360
-13% -$70K 0.13% 103
2024
Q4 		$510K Sell
2,871
-51
-2% -$9.38K 0.12% 103
2024
Q3 		$577K Buy
2,922
+370
+14% +$69.1K 0.13% 103
2024
Q2 		$438K Sell
2,552
-101
-4% -$16.7K 0.11% 107
2024
Q1 		$483K Sell
2,653
-668
-20% -$115K 0.12% 107
2023
Q4 		$515K Sell
3,321
-119
-3% -$17.3K 0.13% 103
2023
Q3 		$513K Buy
3,440
+16
+0.5% +$2.35K 0.15% 97
2023
Q2 		$461K Sell
3,424
-150
-4% -$22K 0.13% 109
2023
Q1 		$570K Buy
3,574
+210
+6% +$32.1K 0.17% 93
2022
Q4 		$544K Buy
+3,364
New +$516K 0.17% 92

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Legacy Trust's ABBV Position: Q3 2026 in Review

Legacy Trust increased its AbbVie (ABBV) stake by 5.1% in Q3 2026, buying an estimated $103K and bringing the position to 8,263 shares worth $2.44M. The position accounts for 0.41% of the portfolio, ranked #60.

Legacy Trust first reported a position in ABBV in Q4 2022 and has held it in 16 quarters since. 2,874 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Legacy Trust held 8,263 shares of AbbVie worth $2.44M as of Q3 2026.
  • Legacy Trust bought 402 AbbVie shares in Q3 2026, an estimated $103K.
  • AbbVie made up 0.41% of Legacy Trust's portfolio in Q3 2026, its #60 holding.
  • Legacy Trust first reported a position in AbbVie in Q4 2022 and has held it in 16 quarters since.
  • 2,874 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Legacy Trust's 13F filing for Q3 2026, filed 6 Nov 2026.